Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Arrowhead Pharmaceuticals's accounts receivables for the quarter that ended in Dec. 2023 was $0.0 Mil.
Accounts receivable can be measured by Days Sales Outstanding.
Arrowhead Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Dec. 2023 was 0.00.
In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Arrowhead Pharmaceuticals's Net-Net Working Capital per share for the quarter that ended in Dec. 2023 was $-2.28.
Arrowhead Pharmaceuticals Accounts Receivable Historical Data
The historical data trend for Arrowhead Pharmaceuticals's Accounts Receivable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.
Arrowhead Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:
2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Arrowhead Pharmaceuticals's accounts receivable are only considered to be worth 75% of book value:
Arrowhead Pharmaceuticals's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2023 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.
If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.
Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.
Arrowhead Pharmaceuticals Accounts Receivable Related Terms
Thank you for viewing the detailed overview of Arrowhead Pharmaceuticals's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.
Arrowhead Pharmaceuticals (Arrowhead Pharmaceuticals) Business Description
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ARWR has been successfully added to your 